NCT02228954View on ClinicalTrials.gov

IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC)

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

March 5, 2018

Study Completion Date

October 19, 2021

Conditions
Clear-cell Metastatic Renal Cell CarcinomaKidney Neoplasms
Interventions
PROCEDURE

Molecular imaging

Trial Locations (3)

Unknown

VU University Medical Center, Amsterdam

University Medical Center Groningen, Groningen

6525GA

Radboudumc, Nijmegen

All Listed Sponsors
collaborator

Dutch Cancer Society

OTHER

lead

Radboud University Medical Center

OTHER

NCT02228954 - IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC) | Biotech Hunter | Biotech Hunter